DK2709656T3 - Proteinmatrix-vaccinesammensætninger omfattende polykationer - Google Patents
Proteinmatrix-vaccinesammensætninger omfattende polykationer Download PDFInfo
- Publication number
- DK2709656T3 DK2709656T3 DK12786365.2T DK12786365T DK2709656T3 DK 2709656 T3 DK2709656 T3 DK 2709656T3 DK 12786365 T DK12786365 T DK 12786365T DK 2709656 T3 DK2709656 T3 DK 2709656T3
- Authority
- DK
- Denmark
- Prior art keywords
- polycations
- vaccine compositions
- protein matrix
- matrix vaccine
- protein
- Prior art date
Links
- 239000011159 matrix material Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161487663P | 2011-05-18 | 2011-05-18 | |
| PCT/US2012/037961 WO2012158701A1 (en) | 2011-05-18 | 2012-05-15 | Protein matrix vaccine compositions including polycations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2709656T3 true DK2709656T3 (da) | 2019-06-24 |
Family
ID=47177310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12786365.2T DK2709656T3 (da) | 2011-05-18 | 2012-05-15 | Proteinmatrix-vaccinesammensætninger omfattende polykationer |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9724401B2 (da) |
| EP (2) | EP2709656B1 (da) |
| JP (1) | JP6072777B2 (da) |
| KR (1) | KR101670340B1 (da) |
| CN (1) | CN103747798B (da) |
| AU (1) | AU2012255878B2 (da) |
| BR (1) | BR112013029417B1 (da) |
| CA (1) | CA2836251C (da) |
| DK (1) | DK2709656T3 (da) |
| ES (1) | ES2728653T3 (da) |
| MX (1) | MX349657B (da) |
| WO (1) | WO2012158701A1 (da) |
| ZA (1) | ZA201309516B (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012164480A1 (en) * | 2011-05-30 | 2012-12-06 | National Institute Of Immunology | A vaccine composition capable of inducing memory antibody response from single point immunization |
| US9931392B2 (en) | 2013-01-18 | 2018-04-03 | London School Of Hygiene And Tropical Medicine | Glycosylation method |
| GB201301085D0 (en) * | 2013-01-22 | 2013-03-06 | London School Hygiene & Tropical Medicine | Glycoconjugate Vaccine |
| FI3583947T3 (fi) * | 2014-01-21 | 2023-10-12 | Pfizer | Streptococcus pneumoniaen kapselipolysakkaridit ja niiden konjugaatit |
| CN104548090B (zh) * | 2015-01-27 | 2016-11-30 | 中国科学院过程工程研究所 | 一种β-葡聚糖修饰的脑膜炎多糖结合疫苗及其制备方法 |
| CN109890413B (zh) | 2016-09-02 | 2024-04-16 | 赛诺菲巴斯德股份有限公司 | 脑膜炎奈瑟氏菌疫苗 |
| JP2020536968A (ja) | 2017-10-13 | 2020-12-17 | ザ リサーチ ファウンデイション フォー ザ ステイト ユニバーシティー オブ ニューヨーク | 共生疾患進行に対する包括的ワクチン設計 |
| EP3720483B1 (en) | 2017-12-06 | 2025-11-19 | Merck Sharp & Dohme LLC | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| EP3897705A2 (en) | 2018-12-19 | 2021-10-27 | Merck Sharp & Dohme Corp. | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0577659B1 (en) | 1991-03-28 | 1996-01-17 | Nycomed Imaging As | Cross-linking agent |
| JP5124066B2 (ja) * | 1999-03-24 | 2013-01-23 | イギリス国 | ポリカチオン性炭水化物のワクチンにおける免疫賦活剤としての使用 |
| AT408721B (de) * | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| US6458387B1 (en) * | 1999-10-18 | 2002-10-01 | Epic Therapeutics, Inc. | Sustained release microspheres |
| US7129222B2 (en) * | 2000-03-10 | 2006-10-31 | Dynavax Technologies Corporation | Immunomodulatory formulations and methods for use thereof |
| SG149013A1 (en) * | 2003-12-17 | 2009-01-29 | Wyeth Corp | Immunogenic peptide carrier conjugates and methods of producing same |
| KR101446238B1 (ko) | 2006-08-07 | 2014-10-01 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 단백질 매트릭스 백신 및 그의 제조방법 및 백신 투여방법 |
| CN110064053A (zh) * | 2006-08-07 | 2019-07-30 | 哈佛大学校长及研究员协会 | 蛋白质基质疫苗及这种疫苗的制备和给药方法 |
| US20090142362A1 (en) | 2006-11-06 | 2009-06-04 | Avant Immunotherapeutics, Inc. | Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP) |
| CA2692021A1 (en) * | 2007-06-28 | 2008-12-31 | Capsutech Ltd | Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers |
| CA2773690A1 (en) | 2009-09-09 | 2011-03-17 | Matrivax Research & Development Corp. | Protein matrix vaccines of improved immunogenicity |
| WO2011036560A2 (en) | 2009-09-23 | 2011-03-31 | Novartis Ag | Glycoconjugate compositions and methods for treatment of hiv |
-
2012
- 2012-05-15 ES ES12786365T patent/ES2728653T3/es active Active
- 2012-05-15 EP EP12786365.2A patent/EP2709656B1/en active Active
- 2012-05-15 CA CA2836251A patent/CA2836251C/en active Active
- 2012-05-15 WO PCT/US2012/037961 patent/WO2012158701A1/en not_active Ceased
- 2012-05-15 US US14/118,552 patent/US9724401B2/en not_active Expired - Fee Related
- 2012-05-15 JP JP2014511458A patent/JP6072777B2/ja not_active Expired - Fee Related
- 2012-05-15 BR BR112013029417-5A patent/BR112013029417B1/pt not_active IP Right Cessation
- 2012-05-15 DK DK12786365.2T patent/DK2709656T3/da active
- 2012-05-15 EP EP19165038.1A patent/EP3524265A1/en not_active Withdrawn
- 2012-05-15 CN CN201280028850.1A patent/CN103747798B/zh not_active Expired - Fee Related
- 2012-05-15 AU AU2012255878A patent/AU2012255878B2/en not_active Ceased
- 2012-05-15 MX MX2013013358A patent/MX349657B/es active IP Right Grant
- 2012-05-15 KR KR1020137033549A patent/KR101670340B1/ko not_active Expired - Fee Related
-
2013
- 2013-12-17 ZA ZA2013/09516A patent/ZA201309516B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR101670340B1 (ko) | 2016-10-28 |
| JP2014513726A (ja) | 2014-06-05 |
| KR20140045416A (ko) | 2014-04-16 |
| ES2728653T3 (es) | 2019-10-28 |
| US9724401B2 (en) | 2017-08-08 |
| BR112013029417B1 (pt) | 2022-10-25 |
| ZA201309516B (en) | 2017-04-26 |
| AU2012255878B2 (en) | 2016-05-12 |
| EP2709656A1 (en) | 2014-03-26 |
| MX2013013358A (es) | 2014-07-09 |
| US20140086989A1 (en) | 2014-03-27 |
| CN103747798B (zh) | 2018-10-26 |
| CA2836251C (en) | 2017-07-04 |
| BR112013029417A2 (pt) | 2017-01-31 |
| EP2709656A4 (en) | 2015-01-14 |
| HK1197033A1 (en) | 2015-01-02 |
| EP2709656B1 (en) | 2019-03-27 |
| WO2012158701A1 (en) | 2012-11-22 |
| JP6072777B2 (ja) | 2017-02-01 |
| MX349657B (es) | 2017-08-08 |
| CN103747798A (zh) | 2014-04-23 |
| AU2012255878A1 (en) | 2013-05-02 |
| EP3524265A1 (en) | 2019-08-14 |
| CA2836251A1 (en) | 2012-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2753345A4 (en) | POLYPEPTIDIMPFSTOFF | |
| DK3170508T3 (da) | Vaccineformuleringer | |
| DK2694038T3 (da) | Farmaceutisk sammensætning | |
| HUE052485T2 (hu) | RNA készítmény immunterápiára | |
| BR112014003052A2 (pt) | composições farmacêuticas | |
| LT2791160T (lt) | Modifikuotos mrnr sudėtys | |
| BR112014009066A2 (pt) | dna triciclo-fosforotioato | |
| CO6930367A2 (es) | Composiciones farmaceúticas | |
| SMT201700110B (it) | Composizione immunogena | |
| EP2755680A4 (en) | PARTICULATE VACCINE FORMULATIONS | |
| CO6940426A2 (es) | Formulaciones farmacéuticas | |
| LT3272861T (lt) | Alfa-galaktozidazės kompozicijos | |
| ZA201309516B (en) | Protein matrix vaccine compositions including polycations | |
| BR112014005756A2 (pt) | vacina | |
| PL2729021T3 (pl) | Żelowa kompozycja | |
| BR112014015885A2 (pt) | preparação farmacêutica | |
| EP2769718A4 (en) | MEDICAL COMPOSITION | |
| EP2742058C0 (en) | ANTI-IL-6 VACCINE COMPOSITION | |
| EP2744480A4 (en) | GELIFYING COMPOSITIONS WITH LOW PROTEIN CONCENTRATION | |
| EP2588135A4 (en) | Nanoemulsion vaccines | |
| IL231660A0 (en) | Composition | |
| BR112014009761A2 (pt) | composição oftálmica | |
| EP2763699A4 (en) | VACCINE | |
| EP2667891A4 (en) | COMBINATION VACCINES | |
| HRP20181667T1 (hr) | Pripravak |